Here are five things to know:
1. CMS approved the “Interbody Fusion Device, Nanotextured Surface” code as an XRG code.
2. Providers may use the code beginning Oct. 1.
3. Mequon, Wis.-based Titan Spine presented its nanoLOCK technology to CMS, showcasing its uniqueness.
4. Titan Spine’s nanoLOCK technology is the only technology approved by CMS to use the code. However, CMS noted it will add other technologies to this code if companies prove equivalence to the nanoLOCK technology.
5. Titan Spine plans to unveil its next-generation nanoLOCK surface technology, designed to offer exceptional osteogenic and angiogenic environments.
More articles on devices:
NuVasive shares increase 1.42% — 5 quick facts
Amedica closes $12.7M public offering: 4 points
Medtronic lays off 4.1% of global spine division staff: 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
